Researchers develop free App for easier blood sugar monitoring in Diabetics

Written By :  Dr. Kamal Kant Kohli
Published On 2020-11-16 05:15 GMT   |   Update On 2020-11-16 09:05 GMT

User scans glucose monitor with GlucoRx, a computer vision technology developed at the University of Cambridge.

CREDIT

James Charles

Advertisement

Researchers at University of Cambridge have developed a free mobile phone app by computer vision technology for regular monitoring of blood sugar levels in people with diabetes.

The app uses computer vision techniques to read and record the blood sugar levels, time and date displayed on a typical glucose test via the camera on a mobile phone. The technology, which doesn't require an internet or Bluetooth connection, works for any type of glucose meter, in any orientation and in a variety of light levels. It also reduces waste by eliminating the need to replace high-quality non-Bluetooth meters, making it a cost-effective solution to the NHS.

Advertisement

Working with UK glucose testing company GlucoRx, the Cambridge researchers have developed the technology into a free mobile phone app, called GlucoRx Vision, which is now available on the Apple App Store and Google Play Store.

To use the app, users simply take a picture of their glucose meter and the results are automatically read and recorded, allowing much easier monitoring of blood glucose levels.

In addition to the glucose meters which people with diabetes use on a daily basis, many other types of digital meters are used in the medical and industrial sectors. However, many of these meters still do not have wireless connectivity, so connecting them to phone tracking apps often requires manual input.

"These meters work perfectly well, so we don't want them sent to landfill just because they don't have wireless connectivity," said Dr James Charles from Cambridge's Department of Engineering. "We wanted to find a way to retrofit them in an inexpensive and environmentally-friendly way using a mobile phone app."

In addition to his interest in solving the challenge from an engineering point of view, Charles also had a personal interest in the problem. He has type 1 diabetes and needs to take as many as ten glucose readings per day. Each reading is then manually entered into a tracking app to help determine how much insulin he needs to regulate his blood glucose levels.

"From a purely selfish point of view, this was something I really wanted to develop," he said.

"We wanted something that was efficient, quick and easy to use," said Professor Roberto Cipolla, also from the Department of Engineering. "Diabetes can affect eyesight or even lead to blindness, so we needed the app to be easy to use for those with reduced vision."

The computer vision technology behind the GlucoRx app is made up of two steps. First, the screen of the glucose meter is detected. The researchers used a single training image and augmented it with random backgrounds, particularly backgrounds with people. This helps ensure the system is robust when the user's face is reflected in the phone's screen.

Second, a neural network called LeDigit detects each digit on the screen and reads it. The network is trained with computer-generated synthetic data, avoiding the need for labour-intensive labelling of data which is commonly needed to train a neural network.

"Since the font on these meters is digital, it's easy to train the neural network to recognise lots of different inputs and synthesise the data," said Charles. "This makes it highly efficient to run on a mobile phone."

"It doesn't matter which orientation the meter is in - we tested it in all types of orientations, viewpoints and light levels," said Cipolla, who is also a Fellow of Jesus College. "The app will vibrate when it's read the information, so you get a clear signal when you've done it correctly. The system is accurate across a range of different types of meters, with read accuracies close to 100%"

In addition to blood sugar monitor, the researchers also tested their system on different types of digital meters, such as blood pressure monitors, kitchen and bathroom scales. The researchers also recently presented their results at the 31st British Machine Vision Conference.

Gluco-Rx initially approached Cipolla's team in 2018 to develop a cost-effective and environmentally-friendly solution to the problem of non-connected glucose meters, and once the technology had been shown to be sufficiently robust, the company worked with the Cambridge researchers to develop the app.

"We have been working in partnership with Cambridge University on this unique solution, which will help change the management of diabetes for years to come," said Chris Chapman, Chief Operating Officer of GlucoRx. "We will soon make this solution available to all of our more than 250,000 patients."

As for Charles, who has been using the app to track his glucose levels, he said it "makes the whole process easier. I've now forgotten what it was like to enter the values in manually, but I do know I wouldn't want to go back to it. There are a few areas in the system which could still be made even better, but all in all I'm very happy with the outcome."


Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News